302
Participants
Start Date
April 30, 2016
Primary Completion Date
May 31, 2017
Study Completion Date
July 31, 2017
Vagifem
One tablet is to be inserted vaginally daily for 2 weeks, then 2 days/week for the remaining 10 weeks of the study.
Replens
2.5 gm to be applied vaginally every 3 days over 12 weeks.
Placebo tablet
Dispensed in visually identical bottle and tablet form to Vagifem.
Placebo gel
Dispensed in visually identical tube and gel form to Replens.
University of Minnesota, Minneapolis
Kaiser Permanente Washington Health Research Institute, Seattle
University of Minnesota
OTHER
Massachusetts General Hospital
OTHER
University of California, San Diego
OTHER
University of Washington
OTHER
Kaiser Permanente
OTHER
Fred Hutchinson Cancer Center
OTHER